Modified Nucleosides
1-(2-Deoxy-beta-D-xylofuranosyl)-5-methyluracil
Quick view. We supply 1-(2-Deoxy-beta-D-xylofuranosyl)-5-methyluracil as a specialty product for nucleic acid chemistry and oligonucleotide research workflows. CAS 16053-52-4. Catalog target purity: Specification on request.
Product profile
1-(2-Deoxy-beta-D-xylofuranosyl)-5-methyluracil is classified as nucleoside or protected nucleoside intermediate (Formula C10H14N2O5; molecular weight 242.23).
1-(2-Deoxy-beta-D-xylofuranosyl)-5-methyluracil can serve as a starting material, protected intermediate or analytical comparator in nucleoside and nucleotide route development.
For 1-(2-Deoxy-beta-D-xylofuranosyl)-5-methyluracil, confirm the current specification, storage conditions and downstream-method compatibility before routine use.
Names and search terms
Confirmed or normalized name variants
- 1-(2-Deoxypentofuranosyl)-4-hydroxy-5-methylpyrimidin-2(1H)-one
- 3’-β-Thymidine
- Thymidine 3''-Epimer
- Zidovudine impurity M
- Stavudine EP Impurity B
- Zidovudine EP Impurity F
- 1-(2'-DEOXY-SS-THREOPENTOFURANOSYL)THYMINE
- 1-(2-Deoxy--D-xylofuranosyl)-5-methyluracil
Useful catalog search terms
- CAS 16053-52-4
- Nucleoside or protected nucleoside intermediate
- Modified Nucleosides
Physicochemical data
| InChI | InChI=1S/C10H14N2O5/c1-5-3-12(10(16)11-9(5)15)8-2-6(14)7(4-13)17-8/h,6-8,13-14H,2,4H2,1H3,(H,11,15,16) |
|---|---|
| InChIKey | IQFYYKKMVGJFEH-UHFFFAOYSA-N |
| SMILES | O=C1N=C(O)C(=CN1C2OC(CO)C(O)C2)C |
Release documentation
The current specification defines the analytical method and acceptance criteria; the released lot result is reported on the CoA.
Additional HPLC, MS or NMR documentation can be agreed during technical review where available.
Additional application examples
- Typical work includes protection/deprotection studies, phosphorylation or phosphitylation route scouting and impurity identification.
- The material can support medicinal-chemistry analog preparation and process-development feasibility studies.
Related products
(S)-cEt-rA
Modified Nucleosides · CAS: 1197033-34-3
BX-OP-0069S-Adenosylmethionine (SAM)
Modified Nucleosides · CAS: 485-80-3
BX-MN-0185(R-/S-) 5-Carbamoylhydroxy methyluridine
Modified Nucleosides · CAS: N/A
BX-MN-0186(R-/S-)5-(1-Hydroxy)(methoxycarbonyl)methyl uridine
Modified Nucleosides · CAS: N/A
BX-MN-0187(R-/S-)5-Carboxyhydroxymethyl uridine
Modified Nucleosides · CAS: N/A
BX-MN-0719(R)-N-(2,3-dihydro-1H-indenyl)adenosine
Modified Nucleosides · CAS: 96392-15-3
Frequently asked questions
Can the package size for 1-(2-Deoxy-beta-D-xylofuranosyl)-5-methyluracil be customized?
Yes. Share the initial quantity, expected future scale, delivery timeline and packaging preference for review.
What information should be included in a quote request?
Quote catalog number BX-MN-0273 and CAS 16053-52-4, the intended research workflow, required quantity and any additional HPLC, MS or NMR documentation needed.
Product-family literature
The publications below provide peer-reviewed context for the Modified Nucleosides product family and its named chemistry.